Quanta Biosciences (Gaithersburg, MD) has developed hundreds of assays for quantifying microRNAs, and has entered into a partnership with Integrated DNA Technologies (Coralville, IA) to custom manufacture them. MicroRNAs have been shown to play a key role in cancer as well as many biological processes including neurological and cardiac function. Quanta’s portfolio of microRNA products […]
Fluidigm has announced that MLL Munich Leukemia Laboratory (www.mll.com) has used the company’s Access Array™ technology to help it uncover mutations in over 80 percent of chronic myelomonocytic leukemia (CMML) patients, providing new insights into the molecular heterogeneity of the disease. MLL researchers applied the unique properties of the Fluidigm Access Array System to prepare […]
CUPERTINO, Calif. – NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, announced that Sanford-Burnham Medical Research Institute has renewed and expanded its license to NextBio Enterprise. The new agreement both expands the Institute’s user-base for NextBio and adds access to […]
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers. The acquisition expands BD’s presence into the emerging affordable personal flow cytometer space, and […]
SEATTLE – Sage Bionetworks and AstraZeneca have initiated a collaboration to make new insights into certain cancers using advanced computational models of disease genetics. This deeper understanding of cancer will potentially help better match patients with appropriate treatments and might one day lead to new cancer therapeutics. The partnership will combine Sage Bionetworks’ expertise in […]
VANCOUVER, British Columbia – RainDance Technologies, Inc., today announced the commercial availability of the ASDSeq™ and XSeq™ Research Screening Panels. Developed in collaboration with Emory University and Greenwood Genetic Center, the two comprehensive panels enable researchers to simultaneously interrogate key genes known to be linked to X-chromosome disorders and syndromic forms of Autism Spectrum Disorder […]
PHILADELPHIA – BioNanomatrix, Inc., a developer of nanoscale, single-molecule imaging and analysis platforms designed to dramatically reduce the time and cost needed to analyze the genome, has closed a $23.3-million Series B round of equity financing. Domain Associates, based in Princeton, N.J., and San Diego, Calif., led the round, with new investor Gund Investment Corporation […]
PORT WASHINGTON, N.Y. – Pall Corporation (NYSE:PLL) today announced that its board of directors has separated the roles of chairman of the board and chief executive officer and elected Ronald L. Hoffman, non-executive chairman. The change is effective today. Mr. Hoffman, a Pall director since 2008, succeeds Eric Krasnoff as chairman. Mr. Krasnoff, who recently […]
Brussels – PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today the launch of three new methods for coupling proteins to the gold nanoparticles used with PharmaDiagnostics’ SoPRanoTM technology. The new coupling methods will greatly expand the technology’s applicability in the key drug […]
St. Louis, MO. – Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq:SIAL), announced that its SAGE Labs initiative has created a suite of knockout rat models of Parkinson’s disease in collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF). Developed using the proprietary SAGEspeed™ model creation process, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
